Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-19

Clinical Trial Update: Safety-and-effectiveness Clinical Evaluation of Nanosecond-pulse Ablation for Atrial Fibrillation [NA]

View source ↗

Summary

Completed clinical evaluation of the safety and effectiveness of nanosecond-pulse ablation for atrial fibrillation. The trial targeted paroxysmal atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shenzhen Pulsecare Medical Technology Co., Ltd. | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED